We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VERA icon
301
Vera Therapeutics
VERA
$2.43B
$7M 0.04%
296,941
-66,751
-18% -$1.5M
INTC icon
302
Intel
INTC
$434B
$6.95M 0.04%
310,395
-6,856
-2% -$142K
MLTX icon
303
MoonLake Immunotherapeutics
MLTX
$1.64B
$6.84M 0.04%
144,830
-29,690
-17% -$1.21M
KKR icon
304
KKR & Co
KKR
$91.4B
$6.74M 0.04%
50,677
-163,867
-76% -$19.2M
KYMR icon
305
Kymera Therapeutics
KYMR
$8.99B
$6.73M 0.04%
+154,103
New +$5.31M
WTS icon
306
Watts Water Technologies
WTS
$11.7B
$6.71M 0.04%
27,304
-24
-0.1% -$5.4K
DOCU
307
DocuSign
DOCU
$10.4B
$6.55M 0.04%
84,116
+33,180
+65% +$2.68M
BX icon
308
Blackstone
BX
$106B
$6.53M 0.04%
43,646
-734
-2% -$101K
BLD
309
DELISTED
TopBuild
BLD
$6.52M 0.04%
20,127
+4,811
+31% +$1.43M
PYPL icon
310
PayPal
PYPL
$50.8B
$6.44M 0.04%
86,607
-48,594
-36% -$3.33M
SNDX icon
311
Syndax Pharmaceuticals
SNDX
$1.78B
$6.32M 0.04%
675,085
+224,650
+50% +$2.47M
UPS icon
312
United Parcel Service
UPS
$91B
$6.28M 0.04%
62,251
+1,317
+2% +$130K
PATH icon
313
UiPath
PATH
$5.97B
$6.2M 0.04%
484,677
-1,305,636
-73% -$15.7M
IDCC icon
314
InterDigital
IDCC
$6.59B
$6.17M 0.04%
+27,507
New +$5.83M
MKC icon
315
McCormick & Company Non-Voting
MKC
$13.8B
$6.16M 0.04%
81,293
-130,935
-62% -$9.81M
GIL icon
316
Gildan
GIL
$9.48B
$6.16M 0.04%
125,321
+46,746
+59% +$2.15M
MRNA icon
317
Moderna
MRNA
$21.5B
$6.1M 0.04%
220,986
-60,960
-22% -$1.61M
ANNX icon
318
Annexon
ANNX
$822M
$6.08M 0.04%
2,534,230
DASH icon
319
DoorDash
DASH
$81.6B
$6.08M 0.04%
24,666
+86
+0.3% +$17.3K
NXT icon
320
Nextpower Inc
NXT
$14.8B
$6.05M 0.03%
111,205
+61,779
+125% +$3.1M
AYI icon
321
Acuity Brands
AYI
$10.1B
$5.9M 0.03%
19,785
-19,633
-50% -$5.08M
HIG icon
322
Hartford Financial Services
HIG
$39.2B
$5.87M 0.03%
46,299
+7,429
+19% +$923K
EXPE icon
323
Expedia Group
EXPE
$34.1B
$5.86M 0.03%
34,726
-18,495
-35% -$3M
MGA icon
324
Magna International
MGA
$18.4B
$5.85M 0.03%
151,536
-1,452
-0.9% -$51.3K
KD icon
325
Kyndryl
KD
$2.86B
$5.81M 0.03%
+138,524
New +$5.01M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.